(Q40232799)

18 September 2017

title

IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells (English)

1 reference

18 September 2017

1 reference

Rosendahl AH

1

1 reference

18 September 2017

Forsberg G

series ordinal

2

1 reference

18 September 2017

language of work or name

English

0 references

publication date

13 September 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

70

1 reference

18 September 2017

issue

9

1 reference

18 September 2017

page(s)

1584-1590

1 reference

Mutations of the VHL tumour suppressor gene in renal carcinoma

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

Inhibition of insulin-like growth factor-I-mediated cell signaling by the von Hippel-Lindau gene product in renal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

Clinical efficacy of cancer subcutaneous immunotherapy with interleukin-2 in relation to the pretreatment levels of tumor growth factor insulin-like growth factor-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

Transforming growth factor beta 1 is significantly elevated in plasma of patients suffering from renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

A non-IGF binding mutant of IGFBP-3 modulates cell function in breast epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

TGF-beta signaling: positive and negative effects on tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

Targeting the TGF beta signaling network in human neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

The L45 loop in type I receptors for TGF-beta family members is a critical determinant in specifying Smad isoform activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001805

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001805

1 reference

18 September 2017

1 reference